ALLARD STEPHANE 4
4 · EPICEPT CORP · Filed Feb 24, 2009
Insider Transaction Report
Form 4
EPICEPT CORPEPCT
ALLARD STEPHANE
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2009-02-20+130,000→ 507,700 totalExercise: $0.56Exp: 2019-02-20→ Common Stock, par value $0.0001 per share (130,000 underlying)
Footnotes (2)
- [F1]The options shall vest in increments upon the achievement of each of the following business objectives: the completion of a Ceplene marketing agreement(s); the completion of a licensing agreement for NP-1; obtaining market approval for Ceplene in the United States; and obtaining market approval for Ceplene in Canada. The exercise of these options is subject to shareholder approval of an increase in the number of shares available under the 2005 Equity Incentive Plan.
- [F2]No consideration was given since option was granted pursuant to a stock option agreement.